UNH Stock Price Today (September 2026) — UnitedHealth Group Incorporated Analysis & Key Metrics 2026-09-04
UnitedHealth Group Incorporated (UNH) is trading at $397.14, down 0.95% today (as of September 2026). The stock continues to show mixed signals with a short-term dip within a broader uptrend, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $475.23 (19.7% upside).
- Volatility remains elevated (16.92% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (40.00% YoY) alongside significant competitive pressures.
UNH Stock Analysis: Key Metrics & Valuation (September 2026)
Concise, actionable data for investors
UnitedHealth Group Incorporated - Historical Price & Volume
Market Cap
Enterprise Value: $398.89B
P/E Ratio
Forward P/E: 17.36
Revenue Growth
Year over Year
Analyst Target
+19.7% upside potential
Key Investor Questions About UNH
What investors need to know before buying
Based on current market data, UNH presents a neutral technical setup with caution warranted fundamentals.
- Technicals say: Neutral (RSI 48.16)
- Fundamentals say: Caution warranted (high leverage concerns)
UNH's growth trajectory depends on its ability to expand within the Healthcare Plans sector while managing margin pressures.
- Future growth will depend on performance in core Healthcare Plans operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for UNH investors include debt exposure and competitive dynamics in the Healthcare Plans industry.
- $73.33B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Healthcare Plans.
52-Week Trading Range
Over the past year, UNH stock traded between $255.97 and $461.62—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 16.92% annualized volatility and β=0.31, the stock exhibits low sensitivity to market moves—making UNH suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.
2 Reasons to Like UNH and 1 to Stay Skeptical
UnitedHealth’s 37.1% return over the past six months has outpaced the S&P 500 by 25.4%, and its stock price has climbed to $400.22 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
UnitedHealth Falls as 30% of Approval Barriers Vanish
Less paperwork may improve access, but investors must watch whether faster approvals weaken medical-cost discipline.
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.
UnitedHealth’s Earnings Beat And Cost Controls Could Be A Game Changer For UnitedHealth Group (UNH)
In recent months, UnitedHealth Group has reported better-than-expected earnings, raised its full-year adjusted EPS outlook, tightened medical cost trends, and moved to remove prior authorization requirements for a wide range of services while accelerating payments to rural hospitals. These steps suggest UnitedHealth Group is reshaping how it manages care delivery and insurer‑provider relationships, potentially reducing bureaucracy and improving member and clinician experience across its vast...
UnitedHealth Is Trouncing the Market in 2026. Is the Stock Still a Buy?
This recovery story is turning into a success story.
3 Sector Stocks to Gain From as Oil, Rates and Jobs Shape September
September's rate and oil pressures could drive sector rotation, favoring energy, financials and defensive healthcare over growth stocks.
UnitedHealth Stock Recovered Before Its Margins Did
UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.
Is UnitedHealth Finally Turning the Corner After a Tough 2025?
UNH is showing signs of recovery as medical costs improve, Optum gains momentum and 2026 earnings guidance rises.
Is UnitedHealth Group (UNH) Finally Turning the Corner Under Stephen Hemsley?
Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]
Explore More Analysis for UNH
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Frequently Asked Questions
Common investor questions about UnitedHealth Group Incorporated
UnitedHealth Group Incorporated (UNH) is currently trading at $397.14. The RSI (14-day) is at 48.2, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $475.23 implies 19.7% upside from current levels. Volatility is low at 16.9% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for UnitedHealth Group Incorporated (UNH): The trailing P/E ratio is 25.75, which is in line with broader market averages. The forward P/E is 17.36, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.22, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 3.65. Price-to-Sales is 0.79. Valuation should be compared to Healthcare Plans industry peers for context, as different sectors trade at different multiples.
Based on 26 analysts covering UNH, the consensus price target is $475.23. This represents a 19.7% upside from the current price of $397.14. The range spans from a low target of $313.00 to a high target of $529.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, UnitedHealth Group Incorporated (UNH) pays a dividend with a current yield of approximately 2.34%. The annualized dividend rate is $8.95 per share. The payout ratio is 57.5%, which is moderate and suggests adequate earnings coverage for the dividend. The most recent ex-dividend date was 2026-09-14T00:00:00.000Z.
Key risks for UnitedHealth Group Incorporated (UNH) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Healthcare Plans sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is UnitedHealth Group Incorporated's (UNH) current debt and financial health profile: Total debt stands at $73.33B. The debt-to-equity ratio is 69.21, which is moderate and generally manageable for most companies. The current ratio is 0.78, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.69. The company holds $31.47B in cash and equivalents. Free cash flow is positive at $24.27B, providing a cushion for debt servicing and shareholder returns.